Extended Data Table 1 ∣.
Pathology outcomes post-treatment
| Overall (N=32) |
|
|---|---|
| Gleason grade group at prostatectomy | |
| 2 | 8 (25.0%) |
| 3 | 9 (28.1%) |
| 4 | 0 (0%) |
| 5 | 15 (46.9%) |
| Gleason sum at prostatectomy | |
| 7 | 17 (53.1%) |
| 8 | 0 (0%) |
| 9-10 | 15 (46.9%) |
| Pathological (surgical) stage | |
| Yes | 32 (100%) |
| Presence of lymphovascular invasion | |
| Yes | 2 (6.3%) |
| No | 30 (93.8%) |
| Presence of extraprostatic extension | |
| Yes | 19 (59.4%) |
| No | 13 (40.6%) |
| Presence of seminal vesicle invasion | |
| Yes | 8 (25.0%) |
| No | 24 (75.0%) |
| Positive margins | |
| Yes | 10 (31.3%) |
| No | 22 (68.8%) |
| Positive lymph nodes | |
| Yes | 4 (12.5%) |
| No | 28 (87.5%) |
| Pathologic Complete Response (pCR) | |
| Yes | 0 (0%) |
| No | 32 (100%) |
| CAPRA-S score | |
| 0-2 | 4 (12.5%) |
| 3-5 | 12 (37.5%) |
| 6 + | 16 (50.0%) |